The Supreme Court tackles patents
The US Supreme Court is in session again and there are two patent cases up for review. First up is MedImmune v Genentech, which essentially deals with current US practice that states a licensee cannot challenge the validity of a licensor’s patent in…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.